{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:48:15Z","timestamp":1793382495494,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004162","name":"Meath Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004162","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Dublin, Trinity College"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) are progressive neurodegenerative syndromes characterised by Parkinsonism with additional features including cognitive dysfunction, falls, and oculomotor abnormalities. Understanding the epidemiology of these conditions is critical to planning for future service provision.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a systematic review of studies reporting incidence and prevalence of CBS and PSP. A search of the PubMed and EMBASE data bases was conducted from their date of inception to 13th July 2021. Meta-analysis of studies sharing similar methodologies was carried out to generate estimated pooled prevalence and incidence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found 32 studies meeting our criteria for inclusion. There were 20 studies with data on prevalence and 12 with incidence data of PSP. Prevalence of CBS was reported in eight studies while seven studies reported incidence. Reported estimates of prevalence for PSP ranged from 1.00 (0.9\u20131.1) to 18 (8\u201328) per 100,000 while prevalence rates for CBS ranged from 0.83 (0.1\u20133.0) to 25 (0\u201359). Incidence rates for PSP and CBS respectively ranged from 0.16 (0.07\u20130.39) to 2.6 per 100,000 person-years and 0.03 (0\u20130.18) to 0.8 (0.4\u20131.3) per 100,000 person-years. A random effects model meta-analysis of studies with similar methodologies yielded a pooled prevalence estimate for PSP of 6.92 (4.33\u201311.06, <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200989%, <jats:italic>\u03c4<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090.3907) and 3.91 (2.03\u20137.51, <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200972%, <jats:italic>\u03c4<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090.2573) per 100,000 for CBS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Studies of the epidemiology of PSP and CBS report highly heterogeneous findings. There is a need for further studies using rigorous phenotyping and the most recent diagnostic criteria to understand the true burden of these conditions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00415-023-11791-2","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T05:01:45Z","timestamp":1686200505000},"page":"4451-4465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8381-7531","authenticated-orcid":false,"given":"Shane","family":"Lyons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Tr\u00e9pel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"O\u2019Dowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"11791_CR1","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1212\/CON.0000000000001158","volume":"28","author":"A Pantelyat","year":"2022","unstructured":"Pantelyat A (2022) Progressive supranuclear palsy and corticobasal syndrome. Continuum (Minneap Minn) 28:1364\u20131378. https:\/\/doi.org\/10.1212\/CON.0000000000001158","journal-title":"Continuum (Minneap Minn)"},{"key":"11791_CR2","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/practneurol-2020-002794","volume":"21","author":"JB Rowe","year":"2021","unstructured":"Rowe JB, Holland N, Rittman T (2021) Progressive supranuclear palsy: diagnosis and management. Pract Neurol 21:376\u2013383. https:\/\/doi.org\/10.1136\/practneurol-2020-002794","journal-title":"Pract Neurol"},{"key":"11791_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.prdoa.2019.08.005","volume":"1","author":"VC Constantinides","year":"2019","unstructured":"Constantinides VC, Paraskevas GP, Paraskevas PG, Stefanis L, Kapaki E (2019) Corticobasal degeneration and corticobasal syndrome: a review. Clin Park Relat Disord 1:66\u201371. https:\/\/doi.org\/10.1016\/j.prdoa.2019.08.005","journal-title":"Clin Park Relat Disord"},{"issue":"Suppl 2","key":"11791_CR4","doi-asserted-by":"publisher","first-page":"II6","DOI":"10.1007\/BF03161076","volume":"246","author":"DW Dickson","year":"1999","unstructured":"Dickson DW (1999) Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246(Suppl 2):II6-15. https:\/\/doi.org\/10.1007\/BF03161076","journal-title":"J Neurol"},{"key":"11791_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1212\/wnl.53.4.795","volume":"53","author":"BF Boeve","year":"1999","unstructured":"Boeve BF, Maraganore DM, Parisi JE, Ahlskog JE, Graff-Radford N, Caselli RJ, Dickson DW, Kokmen E, Petersen RC (1999) Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 53:795\u2013800. https:\/\/doi.org\/10.1212\/wnl.53.4.795","journal-title":"Neurology"},{"key":"11791_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","volume":"10","author":"JC Steele","year":"1964","unstructured":"Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. A heterogenous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 10:333\u2013359. https:\/\/doi.org\/10.1001\/archneur.1964.00460160003001","journal-title":"Arch Neurol"},{"key":"11791_CR7","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU Hoglinger","year":"2017","unstructured":"Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Muller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I, Movement Disorder Society-endorsed PSPSG (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853\u2013864. https:\/\/doi.org\/10.1002\/mds.26987","journal-title":"Mov Disord"},{"key":"11791_CR8","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/mdc3.13489","volume":"9","author":"DMA Swallow","year":"2022","unstructured":"Swallow DMA, Zheng CS, Counsell CE (2022) Systematic review of prevalence studies of progressive supranuclear palsy and corticobasal syndrome. Mov Disord Clin Pract 9:604\u2013613. https:\/\/doi.org\/10.1002\/mdc3.13489","journal-title":"Mov Disord Clin Pract"},{"key":"11791_CR9","unstructured":"Lyons S, O'Dowed S (2021) The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review. PROSPERO CRD420021266193. https:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?RecordID=266193"},{"key":"11791_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","volume":"13","author":"Z Munn","year":"2015","unstructured":"Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C (2015) Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Health 13:147\u2013153. https:\/\/doi.org\/10.1097\/XEB.0000000000000054","journal-title":"Int J Evid Based Health"},{"key":"11791_CR11","unstructured":"Moola S MZ, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P, Lisy K, Mu P-F. (2017) Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z (Ed). Joanna Briggs Reviewer\u2019s Manual. The Joanna Briggs Institute. Available from http:\/\/reviewersmanual.joannabriggs.org\/."},{"key":"11791_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W (2010) Conducting meta-analyses in R with the metafor Package. J Stat Softw 36:1\u201348","journal-title":"J Stat Softw"},{"key":"11791_CR13","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558. https:\/\/doi.org\/10.1002\/sim.1186","journal-title":"Stat Med"},{"key":"11791_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.22966","volume":"25","author":"Y Winter","year":"2010","unstructured":"Winter Y, Bezdolnyy Y, Katunina E, Avakjan G, Reese JP, Klotsche J, Oertel WH, Dodel R, Gusev E (2010) Incidence of Parkinson\u2019s disease and atypical parkinsonism: Russian population-based study. Mov Disord 25:349\u2013356. https:\/\/doi.org\/10.1002\/mds.22966","journal-title":"Mov Disord"},{"key":"11791_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000110150","volume":"7","author":"K Radhakrishnan","year":"1988","unstructured":"Radhakrishnan K, Thacker AK, Maloo JC, Gerryo SE, Mousa ME (1988) Descriptive epidemiology of some rare neurological diseases in Benghazi, Libya. Neuroepidemiology 7:159\u2013164. https:\/\/doi.org\/10.1159\/000110150","journal-title":"Neuroepidemiology"},{"key":"11791_CR16","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1212\/wnl.38.7.1031","volume":"38","author":"LI Golbe","year":"1988","unstructured":"Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC (1988) Prevalence and natural history of progressive supranuclear palsy. Neurology 38:1031\u20131034. https:\/\/doi.org\/10.1212\/wnl.38.7.1031","journal-title":"Neurology"},{"key":"11791_CR17","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1212\/wnl.45.12.2143","volume":"45","author":"MC de Rijk","year":"1995","unstructured":"de Rijk MC, Breteler MM, Graveland GA, Ott A, Grobbee DE, van der Meche FG, Hofman A (1995) Prevalence of Parkinson\u2019s disease in the elderly: the Rotterdam study. Neurology 45:2143\u20132146. https:\/\/doi.org\/10.1212\/wnl.45.12.2143","journal-title":"Neurology"},{"key":"11791_CR18","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1212\/wnl.49.5.1284","volume":"49","author":"JH Bower","year":"1997","unstructured":"Bower JH, Maraganore DM, McDonnell SK, Rocca WA (1997) Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted county, Minnesota, 1976 to 1990. Neurology 49:1284\u20131288. https:\/\/doi.org\/10.1212\/wnl.49.5.1284","journal-title":"Neurology"},{"key":"11791_CR19","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1212\/wnl.49.2.426","volume":"49","author":"L Wermuth","year":"1997","unstructured":"Wermuth L, Joensen P, B\u00fcnger N, Jeune B (1997) High prevalence of Parkinson\u2019s disease in the Faroe Islands. Neurology 49:426\u2013432. https:\/\/doi.org\/10.1212\/wnl.49.2.426","journal-title":"Neurology"},{"key":"11791_CR20","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/mds.870130305","volume":"13","author":"A Chio","year":"1998","unstructured":"Chio A, Magnani C, Schiffer D (1998) Prevalence of Parkinson\u2019s disease in Northwestern Italy: comparison of tracer methodology and clinical ascertainment of cases. Mov Disord 13:400\u2013405. https:\/\/doi.org\/10.1002\/mds.870130305","journal-title":"Mov Disord"},{"key":"11791_CR21","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/s0140-6736(99)04137-9","volume":"354","author":"A Schrag","year":"1999","unstructured":"Schrag A, Ben-Shlomo Y, Quinn NP (1999) Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 354:1771\u20131775. https:\/\/doi.org\/10.1016\/s0140-6736(99)04137-9","journal-title":"Lancet"},{"key":"11791_CR22","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/brain\/124.7.1438","volume":"124","author":"U Nath","year":"2001","unstructured":"Nath U, Ben-Shlomo Y, Thomson RG, Morris HR, Wood NW, Lees AJ, Burn DJ (2001) The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain 124:1438\u20131449. https:\/\/doi.org\/10.1093\/brain\/124.7.1438","journal-title":"Brain"},{"key":"11791_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1046\/j.1440-1819.2001.00779.x","volume":"55","author":"T Yamada","year":"2001","unstructured":"Yamada T, Hattori H, Miura A, Tanabe M, Yamori Y (2001) Prevalence of Alzheimer\u2019s disease, vascular dementia and dementia with lewy bodies in a Japanese population. Psychiatry Clin Neurosci 55:21\u201325. https:\/\/doi.org\/10.1046\/j.1440-1819.2001.00779.x","journal-title":"Psychiatry Clin Neurosci"},{"key":"11791_CR24","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1136\/jnnp.74.9.1206","volume":"74","author":"RJ Harvey","year":"2003","unstructured":"Harvey RJ, Skelton-Robinson M, Rossor MN (2003) The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry 74:1206\u20131209. https:\/\/doi.org\/10.1136\/jnnp.74.9.1206","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11791_CR25","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/mds.10445","volume":"18","author":"ZX Zhang","year":"2003","unstructured":"Zhang ZX, Anderson DW, Huang JB, Li H, Hong X, Wei J, Yang EL, Maraganore DM (2003) Prevalence of Parkinson\u2019s disease and related disorders in the elderly population of greater Beijing. China Mov Disord 18:764\u2013772. https:\/\/doi.org\/10.1002\/mds.10445","journal-title":"China Mov Disord"},{"key":"11791_CR26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00415-004-0333-3","volume":"251","author":"A Bergareche","year":"2004","unstructured":"Bergareche A, De La Puente E, Lopez de Munain A, Sarasqueta C, de Arce A, Poza JJ, Marti-Masso JF (2004) Prevalence of Parkinson\u2019s disease and other types of Parkinsonism. A door-to-door survey in Bidasoa. Spain J Neurol 251:340\u2013345. https:\/\/doi.org\/10.1007\/s00415-004-0333-3","journal-title":"Spain J Neurol"},{"key":"11791_CR27","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/mds.20149","volume":"19","author":"M Kawashima","year":"2004","unstructured":"Kawashima M, Miyake M, Kusumi M, Adachi Y, Nakashima K (2004) Prevalence of progressive supranuclear palsy in Yonago. Japan Mov Disord 19:1239\u20131240. https:\/\/doi.org\/10.1002\/mds.20149","journal-title":"Japan Mov Disord"},{"key":"11791_CR28","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1212\/01.wnl.0000128090.79756.10","volume":"62","author":"LC Tan","year":"2004","unstructured":"Tan LC, Venketasubramanian N, Hong CY, Sahadevan S, Chin JJ, Krishnamoorthy ES, Tan AK, Saw SM (2004) Prevalence of Parkinson disease in Singapore: Chinese vs Malays vs Indians. Neurology 62:1999\u20132004. https:\/\/doi.org\/10.1212\/01.wnl.0000128090.79756.10","journal-title":"Neurology"},{"key":"11791_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1600-0404.2007.00991.x","volume":"118","author":"L Wermuth","year":"2008","unstructured":"Wermuth L, Bech S, Petersen MS, Joensen P, Weihe P, Grandjean P (2008) Prevalence and incidence of Parkinson\u2019s disease in The Faroe Islands. Acta Neurol Scand 118:126\u2013131. https:\/\/doi.org\/10.1111\/j.1600-0404.2007.00991.x","journal-title":"Acta Neurol Scand"},{"key":"11791_CR30","doi-asserted-by":"publisher","first-page":"S264","DOI":"10.1002\/mds.23162","volume":"25","author":"JPSC Tartari","year":"2010","unstructured":"Tartari JPSC, Bauso DJ, Giunta D, Rojas JI, Cristiano E (2010) Prevalence of parkinsonism in a health maintenance organization from Buenos Aires City. Mov Disord 25:S264. https:\/\/doi.org\/10.1002\/mds.23162","journal-title":"Mov Disord"},{"key":"11791_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/mds.22987","volume":"25","author":"J Linder","year":"2010","unstructured":"Linder J, Stenlund H, Forsgren L (2010) Incidence of Parkinson\u2019s disease and parkinsonism in northern Sweden: a population-based study. Mov Disord 25:341\u2013348. https:\/\/doi.org\/10.1002\/mds.22987","journal-title":"Mov Disord"},{"key":"11791_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1600-0404.2010.01442.x","volume":"124","author":"Y Osaki","year":"2011","unstructured":"Osaki Y, Morita Y, Kuwahara T, Miyano I, Doi Y (2011) Prevalence of Parkinson\u2019s disease and atypical parkinsonian syndromes in a rural Japanese district. Acta Neurol Scand. 124:182\u2013187. https:\/\/doi.org\/10.1111\/j.1600-0404.2010.01442.x","journal-title":"Acta Neurol Scand."},{"key":"11791_CR33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/ene.14306","volume":"18","author":"SWIK Nakashita","year":"2011","unstructured":"Nakashita SWIK, Uemura Y, Yamawaki M, Tanaka K, Nakashima K (2011) Parkinsonism in a community dwelling elderly population sample in Japan. Eur J Neurol 18:545. https:\/\/doi.org\/10.1111\/ene.14306","journal-title":"Eur J Neurol"},{"key":"11791_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1001\/jamaneurol.2013.114","volume":"70","author":"R Savica","year":"2013","unstructured":"Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA (2013) Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. JAMA Neurol 70:859\u2013866. https:\/\/doi.org\/10.1001\/jamaneurol.2013.114","journal-title":"JAMA Neurol"},{"key":"11791_CR35","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.parkreldis.2014.04.013","volume":"20","author":"R Caslake","year":"2014","unstructured":"Caslake R, Taylor K, Scott N, Harris C, Gordon J, Wilde K, Murray A, Counsell C (2014) Age-, and gender-specific incidence of vascular parkinsonism, progressive supranuclear palsy, and parkinsonian-type multiple system atrophy in North East Scotland: the PINE study. Parkinsonism Relat Disord 20:834\u2013839. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.04.013","journal-title":"Parkinsonism Relat Disord"},{"key":"11791_CR36","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1017\/S1041610214001835","volume":"26","author":"A Withall","year":"2014","unstructured":"Withall A, Draper B, Seeher K, Brodaty H (2014) The prevalence and causes of younger onset dementia in Eastern Sydney. Australia Int Psychogeriatr 26:1955\u20131965. https:\/\/doi.org\/10.1017\/S1041610214001835","journal-title":"Australia Int Psychogeriatr"},{"key":"11791_CR37","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1179\/1743132815Y.0000000020","volume":"37","author":"EM Khedr","year":"2015","unstructured":"Khedr EM, Fawi G, Abbas MA, Mohammed TA, El-Fetoh NA, Attar GA, Zaki AF (2015) Prevalence of parkinsonism and parkinson\u2019s disease in Qena governorate\/Egypt: a cross-sectional community-based survey. Neurol Res 37:607\u2013618. https:\/\/doi.org\/10.1179\/1743132815Y.0000000020","journal-title":"Neurol Res"},{"key":"11791_CR38","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000002638","volume":"86","author":"IT Coyle-Gilchrist","year":"2016","unstructured":"Coyle-Gilchrist IT, Dick KM, Patterson K, Vazquez Rodriquez P, Wehmann E, Wilcox A, Lansdall CJ, Dawson KE, Wiggins J, Mead S, Brayne C, Rowe JB (2016) Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology 86:1736\u20131743. https:\/\/doi.org\/10.1212\/WNL.0000000000002638","journal-title":"Neurology"},{"key":"11791_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.557","volume":"6","author":"H Takigawa","year":"2016","unstructured":"Takigawa H, Kitayama M, Wada-Isoe K, Kowa H, Nakashima K (2016) Prevalence of progressive supranuclear palsy in Yonago: change throughout a decade. Brain Behav 6:e00557. https:\/\/doi.org\/10.1002\/brb3.557","journal-title":"Brain Behav"},{"key":"11791_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.parkreldis.2018.03.030","volume":"54","author":"V Fleury","year":"2018","unstructured":"Fleury V, Brindel P, Nicastro N, Burkhard PR (2018) Descriptive epidemiology of parkinsonism in the canton of Geneva, Switzerland. Parkinsonism Relat Disord 54:30\u201339. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.03.030","journal-title":"Parkinsonism Relat Disord"},{"key":"11791_CR41","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jalz.2019.03.017","volume":"15","author":"L Calvo-Perxas","year":"2019","unstructured":"Calvo-Perxas L, Belchi O, Turon-Estrada A, Van Eendenburg C, Linares M, Vinas M, Manzano A, Turro-Garriga O, Vilalta-Franch J, Garre-Olmo J (2019) Incidence and characteristics of uncommon dementia subtypes: results from 10 years of clinical surveillance by the registry of dementia of girona. Alzheimers Dement. 15:917\u2013926. https:\/\/doi.org\/10.1016\/j.jalz.2019.03.017","journal-title":"Alzheimers Dement."},{"key":"11791_CR42","doi-asserted-by":"publisher","first-page":"e2355","DOI":"10.1212\/WNL.0000000000007498","volume":"92","author":"G Logroscino","year":"2019","unstructured":"Logroscino G, Piccininni M, Binetti G, Zecca C, Turrone R, Capozzo R, Tortelli R, Battista P, Bagoj E, Barone R, Fostinelli S, Benussi L, Ghidoni R, Padovani A, Cappa SF, Alberici A, Borroni B (2019) Incidence of frontotemporal lobar degeneration in Italy: the salento-brescia registry study. Neurology 92:e2355\u2013e2363. https:\/\/doi.org\/10.1212\/WNL.0000000000007498","journal-title":"Neurology"},{"key":"11791_CR43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3233\/JPD-191744","volume":"10","author":"CD Stang","year":"2020","unstructured":"Stang CD, Turcano P, Mielke MM, Josephs KA, Bower JH, Ahlskog JE, Boeve BF, Martin PR, Upadhyaya SG, Savica R (2020) Incidence and trends of progressive supranuclear palsy and corticobasal syndrome: a population-based study. J Parkinsons Dis 10:179\u2013184. https:\/\/doi.org\/10.3233\/JPD-191744","journal-title":"J Parkinsons Dis"},{"key":"11791_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ene.14306","volume":"27","author":"E Viscidi","year":"2020","unstructured":"Viscidi E, Morris H, Harrington A, Inuzaka Y, Li L, Eaton S, Orlovic M (2020) The epidemiology of progressive supranuclear palsy in the United Kingdom: evidence from the clinical practice research datalink GP online database (CPRD GOLD). Eur J Neurol 27:1\u2013102. https:\/\/doi.org\/10.1111\/ene.14306","journal-title":"Eur J Neurol"},{"key":"11791_CR45","doi-asserted-by":"publisher","first-page":"5718","DOI":"10.3389\/fneur.2021.571800","volume":"12","author":"E Viscidi","year":"2021","unstructured":"Viscidi E, Litvan I, Dam T, Juneja M, Li L, Krzywy H, Eaton S, Hall S, Kupferman J, Hoglinger GU (2021) Clinical Features of Patients With Progressive supranuclear palsy in an US insurance claims database. Front Neurol. 12:5718. https:\/\/doi.org\/10.3389\/fneur.2021.571800","journal-title":"Front Neurol."},{"key":"11791_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12091126","author":"Y Barer","year":"2022","unstructured":"Barer Y, Chodick G, Cohen R, Grabarnik-John M, Ye X, Zamudio J, Gurevich T (2022) Epidemiology of progressive supranuclear palsy: real world data from the second largest health plan in Israel. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci12091126","journal-title":"Brain Sci."},{"key":"11791_CR47","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000525334","volume":"56","author":"DMA Swallow","year":"2022","unstructured":"Swallow DMA, Counsell CE (2022) Prevalence of progressive supranuclear palsy and corticobasal syndrome in Scotland. Neuroepidemiology 56:291\u2013297. https:\/\/doi.org\/10.1159\/000525334","journal-title":"Neuroepidemiology"},{"key":"11791_CR48","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jamaneurol.2022.5128","volume":"80","author":"G Logroscino","year":"2023","unstructured":"Logroscino G, Piccininni M, Graff C, Hardiman O, Ludolph AC, Moreno F, Otto M, Remes AM, Rowe JB, Seelaar H, Solje E, Stefanova E, Traykov L, Jelic V, Rydell MT, Pender N, Anderl-Straub S, Barandiaran M, Gabilondo A, Kr\u00fcger J, Murley AG, Rittman T, van der Ende EL, van Swieten JC, Hartikainen P, Stojmenovic GM, Mehrabian S, Benussi L, Alberici A, Dell\u2019Abate MT, Zecca C, Borroni B (2023) Incidence of syndromes associated with frontotemporal lobar degeneration in 9 European countries. JAMA Neurol 80:279\u2013286. https:\/\/doi.org\/10.1001\/jamaneurol.2022.5128","journal-title":"JAMA Neurol"},{"key":"11791_CR49","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/mds.26054","volume":"29","author":"G Respondek","year":"2014","unstructured":"Respondek G, Stamelou M, Kurz C, Ferguson LW, Rajput A, Chiu WZ, van Swieten JC, Troakes C, Al Sarraj S, Gelpi E, Gaig C, Tolosa E, Oertel WH, Giese A, Roeber S, Arzberger T, Wagenpfeil S, Hoglinger GU, Movement Disorder Society-endorsed PSPSG (2014) The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov Disord. 29:1758\u20131766. https:\/\/doi.org\/10.1002\/mds.26054","journal-title":"Mov Disord."},{"key":"11791_CR50","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mds.27034","volume":"32","author":"G Respondek","year":"2017","unstructured":"Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, Muller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer A, Golbe LI, Litvan I, Stamelou M, Hoglinger GU, Movement Disorder Society-Endorsed PSPSG (2017) Which ante mortem clinical features predict progressive supranuclear palsy pathology? Mov Disord. 32:995\u20131005. https:\/\/doi.org\/10.1002\/mds.27034","journal-title":"Mov Disord."},{"key":"11791_CR51","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1136\/jnnp-2013-307035","volume":"85","author":"SK Alexander","year":"2014","unstructured":"Alexander SK, Rittman T, Xuereb JH, Bak TH, Hodges JR, Rowe JB (2014) Validation of the new consensus criteria for the diagnosis of corticobasal degeneration. J Neurol Neurosurg Psychiatry 85:925\u2013929. https:\/\/doi.org\/10.1136\/jnnp-2013-307035","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"11791_CR52","doi-asserted-by":"publisher","first-page":"016","DOI":"10.1093\/ageing\/afac016","volume":"51","author":"MP Tan","year":"2022","unstructured":"Tan MP (2022) Healthcare for older people in lower and middle income countries. Age Aging 51(4):016. https:\/\/doi.org\/10.1093\/ageing\/afac016","journal-title":"Age Aging"},{"issue":"Pt 4","key":"11791_CR53","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/brain\/awf086","volume":"125","author":"D Caparros-Lefebvre","year":"2002","unstructured":"Caparros-Lefebvre D, Sergeant N, Lees A, Camuzat A, Daniel S, Lannuzel A, Brice A, Tolosa E, Delacourte A, Duyckaerts C (2002) Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. Brain 125(Pt 4):801\u2013811. https:\/\/doi.org\/10.1093\/brain\/awf086","journal-title":"Brain"},{"key":"11791_CR54","doi-asserted-by":"publisher","first-page":"103","DOI":"10.14802\/jmd.20173","volume":"14","author":"HK Park","year":"2021","unstructured":"Park HK, Ilango SD, Litvan I (2021) Environmental risk factors for progressive supranuclear palsy. J Mov Disord 14:103\u2013113. https:\/\/doi.org\/10.14802\/jmd.20173","journal-title":"J Mov Disord"},{"key":"11791_CR55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3233\/JPD-202302","volume":"11","author":"Y Wen","year":"2021","unstructured":"Wen Y, Zhou Y, Jiao B, Shen L (2021) Genetics of progressive supranuclear palsy: a review. J Parkinsons Dis 11:93\u2013105. https:\/\/doi.org\/10.3233\/JPD-202302","journal-title":"J Parkinsons Dis"},{"key":"11791_CR56","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00401-018-1827-x","volume":"135","author":"EB Lee","year":"2018","unstructured":"Lee EB (2018) Integrated neurodegenerative disease autopsy diagnosis. Acta Neuropathol 135:643\u2013646. https:\/\/doi.org\/10.1007\/s00401-018-1827-x","journal-title":"Acta Neuropathol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11791-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-11791-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11791-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T12:07:58Z","timestamp":1691755678000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-11791-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["11791"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-11791-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"assertion":[{"value":"25 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research did not receive specific grants from \nfunding agencies in the public, commercial, or not-for-profit sectors. Dr Lyons has been funded by a \nFellowship from the Meath Foundation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}